about
Portrait of ependymoma recurrence in children: biomarkers of tumor progression identified by dual-color microarray-based gene expression analysisYoung investigator challenge: Cytomorphologic analysis of cerebrospinal fluid in 70 pediatric patients with medulloblastoma and review of the literature focusing on novel diagnostic and prognostic testsA phase II study of sunitinib in patients with recurrent and/or metastatic non-nasopharyngeal head and neck cancer.Integrating Tenascin-C protein expression and 1q25 copy number status in pediatric intracranial ependymoma prognostication: A new model for risk stratification.Neuropathological and neuroradiological spectrum of pediatric malignant gliomas: correlation with outcome.Mesenchymal transition and PDGFRA amplification/mutation are key distinct oncogenic events in pediatric diffuse intrinsic pontine gliomas.Innovative Therapies for Children with Cancer pediatric phase I study of erlotinib in brainstem glioma and relapsing/refractory brain tumorsNeuronal differentiation distinguishes supratentorial and infratentorial childhood ependymomasHistone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypesImaging Microscopic Features of Keratoconic Corneal Morphology.Multimodal optical analysis discriminates freshly extracted human sample of gliomas, metastases and meningiomas from their appropriate controlsImmunohistochemical detection of cytoplasmic LC3 puncta in human cancer specimens.Constitutional mismatch repair deficiency syndrome: clinical description in a French cohort.Preclinical evaluation of dasatinib alone and in combination with cabozantinib for the treatment of diffuse intrinsic pontine glioma.Co-occurrence of histone H3 K27M and BRAF V600E mutations in paediatric midline grade I ganglioglioma.Clinical, Imaging, Histopathological and Molecular Characterization of Anaplastic Ganglioglioma.Copy number gain of 1q25 predicts poor progression-free survival for pediatric intracranial ependymomas and enables patient risk stratification: a prospective European clinical trial cohort analysis on behalf of the Children's Cancer Leukaemia GroupMultimodal optical analysis of meningioma and comparison with histopathology.TMA for all: a new method for the construction of tissue microarrays without recipient paraffin block using custom-built needles.Stromal striae: a new insight into corneal physiology and mechanics.A Global View on the Availability of Methods and Information in the Neuropathological Diagnostics of CNS Tumors: Results of an International Survey Among Neuropathological Units.EPN-12PEDIATRIC SUPRATENTORIAL EPENDYMOMA: COMPARISON BETWEEN IMMUNOHISTOCHEMISTRY, FISH AND DNA METHYLATION ANALYSIS FOR RELA REARRANGEMENT AND HISTOLOGICAL CORRELATION.HG-85INTER-OBSERVER AGREEMENT IN NEUROPATHOLOGICAL HGG DIAGNOSIS : EXPERIENCE OF THE PRE-RANDOMISATION CENTRAL REVIEW IN THE HERBY TRIAL.Primary spindle rhabdomyosarcoma of the breast in an adult female.GENE-06. CO-OCCURRENCE OF DOUBLE MUTATION H3F3A/BRAF IN PEDIATRIC GANGLIOGLIOMAS.Historadiological correlations in high-grade glioma with the histone 3.3 G34R mutation.Diagnostics of Paediatric Supratentorial RELA Ependymomas: Integration of information from Histopathology, Genetics, DNA Methylation and Imaging[Corneal intraepithelial neoplasia: Dysplasia and carcinoma in situ]Cerebrospinal fluid flow increases from newborn to adult stagesH3F3A-G34R mutant high grade neuroepithelial neoplasms with glial and dysplastic ganglion cell componentsBilateral breast lesions in a patient with medullary thyroid carcinomaFine needle aspiration cytology of oxyphilic parathyroid hyperplasiaKIT expression in postradiation sarcomaPediatric methylation class HGNET-MN1: unresolved issues with terminology and gradingChildhood supratentorial ependymomas with YAP1-MAMLD1 fusion: an entity with characteristic clinical, radiological, cytogenetic and histopathological featuresWHO grade has no prognostic value in the pediatric high-grade glioma included in the HERBY trialIntracranial chondromas: A histopathologic and molecular study of three casesYAP1 subgroup supratentorial ependymoma requires TEAD and nuclear factor I-mediated transcriptional programmes for tumorigenesisEPID-09. CMMRD (CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY) ASSOCIATED-BRAIN TUMORS: REPORT FROM THE EUROPEAN C4CMMRD CONSORTIUMDIPG-20. PRE-RANDOMISATION CENTRAL REVIEW AND REAL-TIME BIOMARKERS SCREENING IN THE MULTICENTRE BIOLOGICAL MEDICINE FOR DIPG ERADICATION (BIOMEDE) TRIAL: LESSONS LEARNT FROM THE FIRST 120 BIOPSIES
P50
Q21136141-EB7A7692-45CA-42F5-AAA4-4805D4A5D669Q28080016-4C5ECDAC-C0F0-494A-93C9-0B977074C37DQ33385663-8E9C02E0-10BE-444E-9E60-2F2B114226BCQ33803137-71520D00-06C1-471F-B12F-60B6F1A53E49Q33835128-33D40ADB-90CC-4D51-9B84-627C21AB6EF2Q34184430-58B0CB2F-2F6D-425C-9D6F-0B56F9D525D2Q34480582-5AE8C43E-AD83-4E2D-94E2-4115A1CB4402Q34992547-D5D12827-6DAF-4514-99C6-C0EE30AEDAB4Q36303824-5F847F80-57BE-48D1-BDEA-8B38A768600FQ37391212-D2087274-80B2-4794-84CA-6DE46F4FD38BQ37620564-F8F6CD4B-FAB7-4169-B366-4393597770E0Q37680934-8F08631C-17E3-4B65-8594-65A6A02CBCFAQ38576104-D6EDD2B4-968E-4559-90D9-52F579A5AF0DQ38926034-A697692B-44B4-4D00-AA33-E9C3818484F6Q39094276-876B6490-8E19-42A9-9DBA-8AD466E0D9F3Q39475786-CD2FA715-D16C-4CCD-A04B-0DDC4171CFADQ39652042-F5BEB89E-E799-402F-8599-C17DC3413497Q40001620-20B72495-B233-4DC2-AD3A-305E7B5F3586Q42187895-CA595440-50F1-4D40-ACD0-A96B5F74F795Q42659890-17FC3DD1-2C9F-47C6-969C-62470BA032D9Q43670653-C72A06C2-AC20-48E1-9B31-AC2209D2CF33Q46349663-6951F665-1662-4787-9B37-CF63E7C0B772Q46352322-2FD9FB9D-CE85-4368-8BEC-D7CDCFEF8973Q51549501-5B179D15-93C8-4D97-B611-64BD19F6A870Q54854730-9D9D1505-1B93-4923-A2A0-3F099119E4E3Q55457489-70EFE755-3B09-4E40-8B7E-D9A4F364B62DQ57456192-58BFA428-54BD-4540-BCD5-4414868E2E5EQ57814391-F52045A7-4E75-4239-9404-36DAADF5609FQ58179646-0F0BD2C2-06AF-4C5A-9DFB-4221F185315EQ64266786-D413B139-404A-4F28-B478-4E2119C4797BQ81930364-C3117340-ECE5-4944-B9F2-56F7F0A3F18AQ84753236-509D04C0-76E5-478A-8A07-2065B51C1ED3Q84798640-53A16FC5-C288-443A-A013-ABC84EDAB079Q91214186-734A03A9-4246-444C-BEC0-6FA34372498BQ91674624-85EF1B59-CA51-4FA6-9E5F-2FD895581C18Q92661098-9A33DA5F-4D45-4E89-9625-4BE769097AC3Q92950111-566F536A-8C99-4959-BD0D-59CBBB15CE20Q93063888-AEC24EA5-ED50-4BF3-A494-5F1897453A70Q94065709-1208F650-348D-443F-8C89-877A79767210Q94066150-41D50713-8C0A-4C82-89A1-3FFFE00034CF
P50
description
researcher ORCID ID = 0000-0002-2568-6155
@en
wetenschapper
@nl
name
Felipe Andreiuolo
@ast
Felipe Andreiuolo
@en
Felipe Andreiuolo
@es
Felipe Andreiuolo
@nl
type
label
Felipe Andreiuolo
@ast
Felipe Andreiuolo
@en
Felipe Andreiuolo
@es
Felipe Andreiuolo
@nl
prefLabel
Felipe Andreiuolo
@ast
Felipe Andreiuolo
@en
Felipe Andreiuolo
@es
Felipe Andreiuolo
@nl
P106
P21
P214
630152865641104940008
P31
P496
0000-0002-2568-6155
P7859
viaf-630152865641104940008